Review



qki antibody  (Bethyl)


Bioz Verified Symbol Bethyl is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Bethyl qki antibody
    Qki Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 46 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/bio_rxiv__64898__2026__01__09__698672-209-0-3?v=Bethyl
    Average 93 stars, based on 46 article reviews
    qki antibody - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    92
    Cell Signaling Technology Inc anti pan qki antibody
    Anti Pan Qki Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/pmc13004596-258-27-42?v=Cell+Signaling+Technology+Inc
    Average 92 stars, based on 1 article reviews
    anti pan qki antibody - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    93
    Bethyl qki antibody
    Qki Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/bio_rxiv__64898__2026__01__09__698672-209-0-3?v=Bethyl
    Average 93 stars, based on 1 article reviews
    qki antibody - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rrid ab 2722520 qki cell signaling technology
    Rrid Ab 2722520 Qki Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/pm41351835-685-139-141?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    rrid ab 2722520 qki cell signaling technology - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology qki
    Qki, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/10__1016_slash_j__jrras__2025__102052-100-34-37?v=Santa+Cruz+Biotechnology
    Average 92 stars, based on 1 article reviews
    qki - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti qki
    Rabbit Anti Qki, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/pm41188645-1044-78-80?v=Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti qki - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    qki  (Bethyl)
    93
    Bethyl qki
    a , <t>QKI</t> eCLIP-seq reveals robust and selective binding to U6 snRNA across all stages of human cardiac differentiation (D0, D4, D8). Significance was determined by the Mann-Whitney U test. b , QKI shows negligible enrichment for other spliceosomal snRNAs (U1, U2, U4, U5, U6ATAC, U11, U12, U4atac) compared to U6 snRNA across all stages of human cardiac differentiation. Significance was determined by the Mann-Whitney U test. c, Comparative enrichment analysis of QKI on U6 snRNA (log₂ fold change over size-matched input) relative to 155 ENCODE-profiled RBPs, showing selective U6 engagement (comparable to canonical U6-binding factor SMNDC1) but not to U1 d , QKI shows selective binding to U6 snRNA, but not to the minor spliceosomal U6ATAC snRNA, in contrast to SMNDC1, which binds to both snRNAs. e , QKI binds specifically to the 5ʹ region of U6 snRNA across all stages and replicates, distinct from canonical U6-binding splicing factors (e.g., PRPF8, RBM22), which predominantly bind the 3ʹ region. f , Domain architecture of QKI and schematic of the KH domain double mutant (K120A/R124A) used to assess functional contributions of canonical RNA binding to U6 engagement. g , Normalized read density in eCLIP of transgenic MYC-tagged wild-type and KH domain mutant QKI in HEK293T cells, shown for eCLIP peaks identified in independent experiments <t>with</t> <t>anti-QKI</t> antibody in HEK293T. h , Quantification of ( g ) shows a significant loss of eCLIP signal with the KH domain mutant. i , Enrichment of QKI binding at indicated snRNAs in cells expressing WT or KH mutant QKI indicates that U6 binding is preserved upon mutation of the canonical RNA recognition domain. j , Base-resolution eCLIP mapping of QKI binding to U6 snRNA reveals that the selective enrichment at the 5ʹ stem-loop and adjacent single-stranded region critical for 5ʹSS engagement is preserved in the QKI KH domain mutant. k , RT-PCR using a NIN exon 18 minigene shows that the KH-domain mutant QKI fails to restore splicing despite retaining U6 binding. l, Schematic showing secondary structure of human U6 snRNA with key regions including the 5ʹ stem-loop, 5ʹSS interacting domain, internal stem-loop, and telestem. Colors indicate regions used for NMR analysis. m-o , NMR titration of recombinant QKI KH–QUA2 protein with in vitro transcribed U6 RNA fragments. Residues affected based on chemical shift perturbations overlap with the canonical RNA-binding surfaces. m , The U6 fragment containing both the 13-mer sequence with a partial QRE motif and the 5ʹ stem-loop induces the strongest chemical shift changes, consistent with an extended RNA-binding interface and a higher affinity interaction. n , The 13-mer alone also triggers pronounced shifts, yet to a lesser extent compared to ( m ). o , In contrast, the 5ʹ stem-loop alone causes only minor perturbations, consistent with a weak interaction. Error bars represent ±SEM; p- values are calculated using Student’s t -test; biological replicates n = 3
    Qki, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/bio_rxiv__2025__09__04__674271-532-47-53?v=Bethyl
    Average 93 stars, based on 1 article reviews
    qki - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Bethyl anti qki antibody
    a , <t>QKI</t> eCLIP-seq reveals robust and selective binding to U6 snRNA across all stages of human cardiac differentiation (D0, D4, D8). Significance was determined by the Mann-Whitney U test. b , QKI shows negligible enrichment for other spliceosomal snRNAs (U1, U2, U4, U5, U6ATAC, U11, U12, U4atac) compared to U6 snRNA across all stages of human cardiac differentiation. Significance was determined by the Mann-Whitney U test. c, Comparative enrichment analysis of QKI on U6 snRNA (log₂ fold change over size-matched input) relative to 155 ENCODE-profiled RBPs, showing selective U6 engagement (comparable to canonical U6-binding factor SMNDC1) but not to U1 d , QKI shows selective binding to U6 snRNA, but not to the minor spliceosomal U6ATAC snRNA, in contrast to SMNDC1, which binds to both snRNAs. e , QKI binds specifically to the 5ʹ region of U6 snRNA across all stages and replicates, distinct from canonical U6-binding splicing factors (e.g., PRPF8, RBM22), which predominantly bind the 3ʹ region. f , Domain architecture of QKI and schematic of the KH domain double mutant (K120A/R124A) used to assess functional contributions of canonical RNA binding to U6 engagement. g , Normalized read density in eCLIP of transgenic MYC-tagged wild-type and KH domain mutant QKI in HEK293T cells, shown for eCLIP peaks identified in independent experiments <t>with</t> <t>anti-QKI</t> antibody in HEK293T. h , Quantification of ( g ) shows a significant loss of eCLIP signal with the KH domain mutant. i , Enrichment of QKI binding at indicated snRNAs in cells expressing WT or KH mutant QKI indicates that U6 binding is preserved upon mutation of the canonical RNA recognition domain. j , Base-resolution eCLIP mapping of QKI binding to U6 snRNA reveals that the selective enrichment at the 5ʹ stem-loop and adjacent single-stranded region critical for 5ʹSS engagement is preserved in the QKI KH domain mutant. k , RT-PCR using a NIN exon 18 minigene shows that the KH-domain mutant QKI fails to restore splicing despite retaining U6 binding. l, Schematic showing secondary structure of human U6 snRNA with key regions including the 5ʹ stem-loop, 5ʹSS interacting domain, internal stem-loop, and telestem. Colors indicate regions used for NMR analysis. m-o , NMR titration of recombinant QKI KH–QUA2 protein with in vitro transcribed U6 RNA fragments. Residues affected based on chemical shift perturbations overlap with the canonical RNA-binding surfaces. m , The U6 fragment containing both the 13-mer sequence with a partial QRE motif and the 5ʹ stem-loop induces the strongest chemical shift changes, consistent with an extended RNA-binding interface and a higher affinity interaction. n , The 13-mer alone also triggers pronounced shifts, yet to a lesser extent compared to ( m ). o , In contrast, the 5ʹ stem-loop alone causes only minor perturbations, consistent with a weak interaction. Error bars represent ±SEM; p- values are calculated using Student’s t -test; biological replicates n = 3
    Anti Qki Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/bio_rxiv__2025__09__04__674271-501-20-23?v=Bethyl
    Average 93 stars, based on 1 article reviews
    anti qki antibody - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    NeuroMab qki7
    a-c, Subcellular distribution of QKI isoforms (red) and their co-localization with ATXN2 (green) were investigated using Oli-neu cells under normal and oxidative stress conditions. DAPI (blue) marks the nuclei. Under normal growth conditions, QKI5 showed a nuclear localization, while QKI6 and <t>QKI7</t> were detected in both cytosol and nucleus. Under oxidative stress induced by sodium-arsenite (NaAsO 2 ), QKI6 showed the highest rate of association with the SGs marked by ATXN2, although a portion of QKI7 and a smaller portion of QKI5 also co-localized with SGs. Insets marked with yellow squares in NaAsO 2 images were shown enlarged in lower panels. White dotted lines mark the straightened segments shown below. Normalized plot profiles of each channel in straightened segments depict the co-localization of respective QKI isoform with ATXN2 in SGs. d, Separation of WT and KIN cerebella at the terminal stage into PN (soluble) and Urea (insoluble) fractions showed an increased abundance of QKI6 and QKI7 to co-fractionate with mutant ATXN2 in the insoluble fraction (red arrows). The segregation of both QKI isoforms at different levels than that of their original size (≈35 kDa) in Urea fraction is suspected to be the result of post-translational modifications they encounter at the aggregates. e-h, Immunohistochemical assessment of ATXN2 and QKI6 co-aggregation in PDGFRα- positive and negative cells of the white matter (OPCs and more mature stages of the lineage, respectively). At least two sections were imaged from three WT and KIN animals with similar findings.
    Qki7, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/bio_rxiv__2025__08__08__669189-105-27-28?v=NeuroMab
    Average 93 stars, based on 1 article reviews
    qki7 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    NeuroMab qki6
    a-c, Subcellular distribution of QKI isoforms (red) and their co-localization with ATXN2 (green) were investigated using Oli-neu cells under normal and oxidative stress conditions. DAPI (blue) marks the nuclei. Under normal growth conditions, QKI5 showed a nuclear localization, while <t>QKI6</t> and QKI7 were detected in both cytosol and nucleus. Under oxidative stress induced by sodium-arsenite (NaAsO 2 ), QKI6 showed the highest rate of association with the SGs marked by ATXN2, although a portion of QKI7 and a smaller portion of QKI5 also co-localized with SGs. Insets marked with yellow squares in NaAsO 2 images were shown enlarged in lower panels. White dotted lines mark the straightened segments shown below. Normalized plot profiles of each channel in straightened segments depict the co-localization of respective QKI isoform with ATXN2 in SGs. d, Separation of WT and KIN cerebella at the terminal stage into PN (soluble) and Urea (insoluble) fractions showed an increased abundance of QKI6 and QKI7 to co-fractionate with mutant ATXN2 in the insoluble fraction (red arrows). The segregation of both QKI isoforms at different levels than that of their original size (≈35 kDa) in Urea fraction is suspected to be the result of post-translational modifications they encounter at the aggregates. e-h, Immunohistochemical assessment of ATXN2 and QKI6 co-aggregation in PDGFRα- positive and negative cells of the white matter (OPCs and more mature stages of the lineage, respectively). At least two sections were imaged from three WT and KIN animals with similar findings.
    Qki6, supplied by NeuroMab, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/qki/bio_rxiv__2025__08__08__669189-84-46-47?v=NeuroMab
    Average 93 stars, based on 1 article reviews
    qki6 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    a , QKI eCLIP-seq reveals robust and selective binding to U6 snRNA across all stages of human cardiac differentiation (D0, D4, D8). Significance was determined by the Mann-Whitney U test. b , QKI shows negligible enrichment for other spliceosomal snRNAs (U1, U2, U4, U5, U6ATAC, U11, U12, U4atac) compared to U6 snRNA across all stages of human cardiac differentiation. Significance was determined by the Mann-Whitney U test. c, Comparative enrichment analysis of QKI on U6 snRNA (log₂ fold change over size-matched input) relative to 155 ENCODE-profiled RBPs, showing selective U6 engagement (comparable to canonical U6-binding factor SMNDC1) but not to U1 d , QKI shows selective binding to U6 snRNA, but not to the minor spliceosomal U6ATAC snRNA, in contrast to SMNDC1, which binds to both snRNAs. e , QKI binds specifically to the 5ʹ region of U6 snRNA across all stages and replicates, distinct from canonical U6-binding splicing factors (e.g., PRPF8, RBM22), which predominantly bind the 3ʹ region. f , Domain architecture of QKI and schematic of the KH domain double mutant (K120A/R124A) used to assess functional contributions of canonical RNA binding to U6 engagement. g , Normalized read density in eCLIP of transgenic MYC-tagged wild-type and KH domain mutant QKI in HEK293T cells, shown for eCLIP peaks identified in independent experiments with anti-QKI antibody in HEK293T. h , Quantification of ( g ) shows a significant loss of eCLIP signal with the KH domain mutant. i , Enrichment of QKI binding at indicated snRNAs in cells expressing WT or KH mutant QKI indicates that U6 binding is preserved upon mutation of the canonical RNA recognition domain. j , Base-resolution eCLIP mapping of QKI binding to U6 snRNA reveals that the selective enrichment at the 5ʹ stem-loop and adjacent single-stranded region critical for 5ʹSS engagement is preserved in the QKI KH domain mutant. k , RT-PCR using a NIN exon 18 minigene shows that the KH-domain mutant QKI fails to restore splicing despite retaining U6 binding. l, Schematic showing secondary structure of human U6 snRNA with key regions including the 5ʹ stem-loop, 5ʹSS interacting domain, internal stem-loop, and telestem. Colors indicate regions used for NMR analysis. m-o , NMR titration of recombinant QKI KH–QUA2 protein with in vitro transcribed U6 RNA fragments. Residues affected based on chemical shift perturbations overlap with the canonical RNA-binding surfaces. m , The U6 fragment containing both the 13-mer sequence with a partial QRE motif and the 5ʹ stem-loop induces the strongest chemical shift changes, consistent with an extended RNA-binding interface and a higher affinity interaction. n , The 13-mer alone also triggers pronounced shifts, yet to a lesser extent compared to ( m ). o , In contrast, the 5ʹ stem-loop alone causes only minor perturbations, consistent with a weak interaction. Error bars represent ±SEM; p- values are calculated using Student’s t -test; biological replicates n = 3

    Journal: bioRxiv

    Article Title: QKI ensures splicing fidelity during cardiogenesis by engaging the U6 tri-snRNP to activate splicing at weak 5ʹ splice sites

    doi: 10.1101/2025.09.04.674271

    Figure Lengend Snippet: a , QKI eCLIP-seq reveals robust and selective binding to U6 snRNA across all stages of human cardiac differentiation (D0, D4, D8). Significance was determined by the Mann-Whitney U test. b , QKI shows negligible enrichment for other spliceosomal snRNAs (U1, U2, U4, U5, U6ATAC, U11, U12, U4atac) compared to U6 snRNA across all stages of human cardiac differentiation. Significance was determined by the Mann-Whitney U test. c, Comparative enrichment analysis of QKI on U6 snRNA (log₂ fold change over size-matched input) relative to 155 ENCODE-profiled RBPs, showing selective U6 engagement (comparable to canonical U6-binding factor SMNDC1) but not to U1 d , QKI shows selective binding to U6 snRNA, but not to the minor spliceosomal U6ATAC snRNA, in contrast to SMNDC1, which binds to both snRNAs. e , QKI binds specifically to the 5ʹ region of U6 snRNA across all stages and replicates, distinct from canonical U6-binding splicing factors (e.g., PRPF8, RBM22), which predominantly bind the 3ʹ region. f , Domain architecture of QKI and schematic of the KH domain double mutant (K120A/R124A) used to assess functional contributions of canonical RNA binding to U6 engagement. g , Normalized read density in eCLIP of transgenic MYC-tagged wild-type and KH domain mutant QKI in HEK293T cells, shown for eCLIP peaks identified in independent experiments with anti-QKI antibody in HEK293T. h , Quantification of ( g ) shows a significant loss of eCLIP signal with the KH domain mutant. i , Enrichment of QKI binding at indicated snRNAs in cells expressing WT or KH mutant QKI indicates that U6 binding is preserved upon mutation of the canonical RNA recognition domain. j , Base-resolution eCLIP mapping of QKI binding to U6 snRNA reveals that the selective enrichment at the 5ʹ stem-loop and adjacent single-stranded region critical for 5ʹSS engagement is preserved in the QKI KH domain mutant. k , RT-PCR using a NIN exon 18 minigene shows that the KH-domain mutant QKI fails to restore splicing despite retaining U6 binding. l, Schematic showing secondary structure of human U6 snRNA with key regions including the 5ʹ stem-loop, 5ʹSS interacting domain, internal stem-loop, and telestem. Colors indicate regions used for NMR analysis. m-o , NMR titration of recombinant QKI KH–QUA2 protein with in vitro transcribed U6 RNA fragments. Residues affected based on chemical shift perturbations overlap with the canonical RNA-binding surfaces. m , The U6 fragment containing both the 13-mer sequence with a partial QRE motif and the 5ʹ stem-loop induces the strongest chemical shift changes, consistent with an extended RNA-binding interface and a higher affinity interaction. n , The 13-mer alone also triggers pronounced shifts, yet to a lesser extent compared to ( m ). o , In contrast, the 5ʹ stem-loop alone causes only minor perturbations, consistent with a weak interaction. Error bars represent ±SEM; p- values are calculated using Student’s t -test; biological replicates n = 3

    Article Snippet: During cell lysis incubation, beads were coupled to antibodies as follows; 125 μl per sample of sheep anti-rabbit Dynabeads M-280 (Cat# 11204D, Life Technologies) was washed twice in co-IP lysis buffer and incubated with 10 μg/sample (10 cm plate) or 15 μg/sample (15 cm plate) of either QKI (Cat# A300-183A), RBM42 (Cat# A305-138A, Bethyl Laboratories), SNRNP27 (Cat# HPA034541, Sigma-Aldrich) or TXNL4A (Cat# PA5-120069, Thermo Fischer Scientific) antibodies for 45 minutes at room temperature on a rotator.

    Techniques: Binding Assay, MANN-WHITNEY, Mutagenesis, Functional Assay, RNA Binding Assay, Transgenic Assay, Expressing, Reverse Transcription Polymerase Chain Reaction, Titration, Recombinant, In Vitro, Sequencing

    a , Schematic of the RNA-aware nuclear complexome and IP-proteome workflows. UV-crosslinked nuclei from WT and QKI KO cardiomyocytes were subjected to BN-PAGE and LC-MS/MS with or without RNase treatment (complexome), or immunoprecipitation of endogenous QKI followed by RNase-treated LC-MS/MS (IP proteome). b , RNA-aware complexome profiling without RNase reveals extensive co-migration of QKI with spliceosomal assemblies, including PRPF38A, TXNL4A, USP39, SMU1, RBM42, and SNRNP27, suggesting RNA-mediated interactions with multiple splicing stages. c , RNase-treated complexome narrows the QKI interactome, retaining defined associations with early spliceosomal and tri-snRNP proteins, indicating direct protein-protein interactions independent of RNA. d , RNase-treated immunoprecipitation proteome confirms a coherent subset of QKI interactors— TXNL4A, PRPF4, SMU1, RBM42, USP39, and SART1, overlapping with complexome results and highlighting QKI association with early spliceosome complexes. e-g , Western blot validation of QKI co-immunoprecipitation with ( e )TXNL4A, ( f ) SNRNP27, and ( g ) RBM42 confirms direct interaction with QKI.

    Journal: bioRxiv

    Article Title: QKI ensures splicing fidelity during cardiogenesis by engaging the U6 tri-snRNP to activate splicing at weak 5ʹ splice sites

    doi: 10.1101/2025.09.04.674271

    Figure Lengend Snippet: a , Schematic of the RNA-aware nuclear complexome and IP-proteome workflows. UV-crosslinked nuclei from WT and QKI KO cardiomyocytes were subjected to BN-PAGE and LC-MS/MS with or without RNase treatment (complexome), or immunoprecipitation of endogenous QKI followed by RNase-treated LC-MS/MS (IP proteome). b , RNA-aware complexome profiling without RNase reveals extensive co-migration of QKI with spliceosomal assemblies, including PRPF38A, TXNL4A, USP39, SMU1, RBM42, and SNRNP27, suggesting RNA-mediated interactions with multiple splicing stages. c , RNase-treated complexome narrows the QKI interactome, retaining defined associations with early spliceosomal and tri-snRNP proteins, indicating direct protein-protein interactions independent of RNA. d , RNase-treated immunoprecipitation proteome confirms a coherent subset of QKI interactors— TXNL4A, PRPF4, SMU1, RBM42, USP39, and SART1, overlapping with complexome results and highlighting QKI association with early spliceosome complexes. e-g , Western blot validation of QKI co-immunoprecipitation with ( e )TXNL4A, ( f ) SNRNP27, and ( g ) RBM42 confirms direct interaction with QKI.

    Article Snippet: During cell lysis incubation, beads were coupled to antibodies as follows; 125 μl per sample of sheep anti-rabbit Dynabeads M-280 (Cat# 11204D, Life Technologies) was washed twice in co-IP lysis buffer and incubated with 10 μg/sample (10 cm plate) or 15 μg/sample (15 cm plate) of either QKI (Cat# A300-183A), RBM42 (Cat# A305-138A, Bethyl Laboratories), SNRNP27 (Cat# HPA034541, Sigma-Aldrich) or TXNL4A (Cat# PA5-120069, Thermo Fischer Scientific) antibodies for 45 minutes at room temperature on a rotator.

    Techniques: Liquid Chromatography with Mass Spectroscopy, Immunoprecipitation, Migration, Protein-Protein interactions, Western Blot, Biomarker Discovery

    a-c, Subcellular distribution of QKI isoforms (red) and their co-localization with ATXN2 (green) were investigated using Oli-neu cells under normal and oxidative stress conditions. DAPI (blue) marks the nuclei. Under normal growth conditions, QKI5 showed a nuclear localization, while QKI6 and QKI7 were detected in both cytosol and nucleus. Under oxidative stress induced by sodium-arsenite (NaAsO 2 ), QKI6 showed the highest rate of association with the SGs marked by ATXN2, although a portion of QKI7 and a smaller portion of QKI5 also co-localized with SGs. Insets marked with yellow squares in NaAsO 2 images were shown enlarged in lower panels. White dotted lines mark the straightened segments shown below. Normalized plot profiles of each channel in straightened segments depict the co-localization of respective QKI isoform with ATXN2 in SGs. d, Separation of WT and KIN cerebella at the terminal stage into PN (soluble) and Urea (insoluble) fractions showed an increased abundance of QKI6 and QKI7 to co-fractionate with mutant ATXN2 in the insoluble fraction (red arrows). The segregation of both QKI isoforms at different levels than that of their original size (≈35 kDa) in Urea fraction is suspected to be the result of post-translational modifications they encounter at the aggregates. e-h, Immunohistochemical assessment of ATXN2 and QKI6 co-aggregation in PDGFRα- positive and negative cells of the white matter (OPCs and more mature stages of the lineage, respectively). At least two sections were imaged from three WT and KIN animals with similar findings.

    Journal: bioRxiv

    Article Title: ATXN2 polyglutamine expansion impairs QKI-dependent alternative splicing and oligodendrocyte maintenance

    doi: 10.1101/2025.08.08.669189

    Figure Lengend Snippet: a-c, Subcellular distribution of QKI isoforms (red) and their co-localization with ATXN2 (green) were investigated using Oli-neu cells under normal and oxidative stress conditions. DAPI (blue) marks the nuclei. Under normal growth conditions, QKI5 showed a nuclear localization, while QKI6 and QKI7 were detected in both cytosol and nucleus. Under oxidative stress induced by sodium-arsenite (NaAsO 2 ), QKI6 showed the highest rate of association with the SGs marked by ATXN2, although a portion of QKI7 and a smaller portion of QKI5 also co-localized with SGs. Insets marked with yellow squares in NaAsO 2 images were shown enlarged in lower panels. White dotted lines mark the straightened segments shown below. Normalized plot profiles of each channel in straightened segments depict the co-localization of respective QKI isoform with ATXN2 in SGs. d, Separation of WT and KIN cerebella at the terminal stage into PN (soluble) and Urea (insoluble) fractions showed an increased abundance of QKI6 and QKI7 to co-fractionate with mutant ATXN2 in the insoluble fraction (red arrows). The segregation of both QKI isoforms at different levels than that of their original size (≈35 kDa) in Urea fraction is suspected to be the result of post-translational modifications they encounter at the aggregates. e-h, Immunohistochemical assessment of ATXN2 and QKI6 co-aggregation in PDGFRα- positive and negative cells of the white matter (OPCs and more mature stages of the lineage, respectively). At least two sections were imaged from three WT and KIN animals with similar findings.

    Article Snippet: Primary antibody incubation was done in blocking buffer using ATXN2 (BD Biosciences #611378, 1:100), PABP1 (Abcam #ab21060, 1:300), QKI5 (Merck Millipore #MABN661, 1:100) QKI6 (Neuromab #75-190, 1:200), QKI7 (Neuromab #75-200, 1:100) antibodies o/n at 4°C.

    Techniques: Mutagenesis, Immunohistochemical staining

    a, Protein levels of QKI5, QKI6 and QKI7 were measured in KIN cerebellum (Cb) at pre-onset (3 mo) and terminal (14 mo) disease stages with age-matched WT controls. QKI5 remained upregulated and QKI7 remained downregulated in KIN tissue throughout the disease course, but QKI6 showed a pre-onset upregulation that transformed into a strong downregulation at the terminal stage, mimicking a profile usually displayed by proteins sequestrated into aggregation in the disease course. ACTB was used as loading control in quantitative immunoblots. Each data point represents a single animal. b, Immunohistochemical assessment of QKI6 (green) localization in WT and KIN cerebellar WM at the terminal stage (14 mo) showed its diffuse cytosolic distribution in WT samples, and its sequestration into cytosolic aggregates in KIN samples marked by SG marker PABP (red). DAPI (blue) marks the nuclei. Transcript levels of Qki5 , Qki6 and Qki7 were measured with specific primers designed for qRT-PCR in KIN (c) , KO (d) and transgenic (Tg) ATXN2 -Q58 mouse (e) tissues at different disease stages with age-matched WT controls. Only late-onset dysregulations were observed in KIN cerebellum (Cb) and spinal cord (SC), without a change in KO or Tg ATXN2 -Q58 cerebellum. Actb was used as housekeeping gene in qRT-PCR experiments. Each data point represents a single animal.

    Journal: bioRxiv

    Article Title: ATXN2 polyglutamine expansion impairs QKI-dependent alternative splicing and oligodendrocyte maintenance

    doi: 10.1101/2025.08.08.669189

    Figure Lengend Snippet: a, Protein levels of QKI5, QKI6 and QKI7 were measured in KIN cerebellum (Cb) at pre-onset (3 mo) and terminal (14 mo) disease stages with age-matched WT controls. QKI5 remained upregulated and QKI7 remained downregulated in KIN tissue throughout the disease course, but QKI6 showed a pre-onset upregulation that transformed into a strong downregulation at the terminal stage, mimicking a profile usually displayed by proteins sequestrated into aggregation in the disease course. ACTB was used as loading control in quantitative immunoblots. Each data point represents a single animal. b, Immunohistochemical assessment of QKI6 (green) localization in WT and KIN cerebellar WM at the terminal stage (14 mo) showed its diffuse cytosolic distribution in WT samples, and its sequestration into cytosolic aggregates in KIN samples marked by SG marker PABP (red). DAPI (blue) marks the nuclei. Transcript levels of Qki5 , Qki6 and Qki7 were measured with specific primers designed for qRT-PCR in KIN (c) , KO (d) and transgenic (Tg) ATXN2 -Q58 mouse (e) tissues at different disease stages with age-matched WT controls. Only late-onset dysregulations were observed in KIN cerebellum (Cb) and spinal cord (SC), without a change in KO or Tg ATXN2 -Q58 cerebellum. Actb was used as housekeeping gene in qRT-PCR experiments. Each data point represents a single animal.

    Article Snippet: Primary antibody incubation was done in blocking buffer using ATXN2 (BD Biosciences #611378, 1:100), PABP1 (Abcam #ab21060, 1:300), QKI5 (Merck Millipore #MABN661, 1:100) QKI6 (Neuromab #75-190, 1:200), QKI7 (Neuromab #75-200, 1:100) antibodies o/n at 4°C.

    Techniques: Transformation Assay, Control, Western Blot, Immunohistochemical staining, Marker, Quantitative RT-PCR, Transgenic Assay

    a-c, Subcellular distribution of QKI isoforms (red) and their co-localization with ATXN2 (green) were investigated using Oli-neu cells under normal and oxidative stress conditions. DAPI (blue) marks the nuclei. Under normal growth conditions, QKI5 showed a nuclear localization, while QKI6 and QKI7 were detected in both cytosol and nucleus. Under oxidative stress induced by sodium-arsenite (NaAsO 2 ), QKI6 showed the highest rate of association with the SGs marked by ATXN2, although a portion of QKI7 and a smaller portion of QKI5 also co-localized with SGs. Insets marked with yellow squares in NaAsO 2 images were shown enlarged in lower panels. White dotted lines mark the straightened segments shown below. Normalized plot profiles of each channel in straightened segments depict the co-localization of respective QKI isoform with ATXN2 in SGs. d, Separation of WT and KIN cerebella at the terminal stage into PN (soluble) and Urea (insoluble) fractions showed an increased abundance of QKI6 and QKI7 to co-fractionate with mutant ATXN2 in the insoluble fraction (red arrows). The segregation of both QKI isoforms at different levels than that of their original size (≈35 kDa) in Urea fraction is suspected to be the result of post-translational modifications they encounter at the aggregates. e-h, Immunohistochemical assessment of ATXN2 and QKI6 co-aggregation in PDGFRα- positive and negative cells of the white matter (OPCs and more mature stages of the lineage, respectively). At least two sections were imaged from three WT and KIN animals with similar findings.

    Journal: bioRxiv

    Article Title: ATXN2 polyglutamine expansion impairs QKI-dependent alternative splicing and oligodendrocyte maintenance

    doi: 10.1101/2025.08.08.669189

    Figure Lengend Snippet: a-c, Subcellular distribution of QKI isoforms (red) and their co-localization with ATXN2 (green) were investigated using Oli-neu cells under normal and oxidative stress conditions. DAPI (blue) marks the nuclei. Under normal growth conditions, QKI5 showed a nuclear localization, while QKI6 and QKI7 were detected in both cytosol and nucleus. Under oxidative stress induced by sodium-arsenite (NaAsO 2 ), QKI6 showed the highest rate of association with the SGs marked by ATXN2, although a portion of QKI7 and a smaller portion of QKI5 also co-localized with SGs. Insets marked with yellow squares in NaAsO 2 images were shown enlarged in lower panels. White dotted lines mark the straightened segments shown below. Normalized plot profiles of each channel in straightened segments depict the co-localization of respective QKI isoform with ATXN2 in SGs. d, Separation of WT and KIN cerebella at the terminal stage into PN (soluble) and Urea (insoluble) fractions showed an increased abundance of QKI6 and QKI7 to co-fractionate with mutant ATXN2 in the insoluble fraction (red arrows). The segregation of both QKI isoforms at different levels than that of their original size (≈35 kDa) in Urea fraction is suspected to be the result of post-translational modifications they encounter at the aggregates. e-h, Immunohistochemical assessment of ATXN2 and QKI6 co-aggregation in PDGFRα- positive and negative cells of the white matter (OPCs and more mature stages of the lineage, respectively). At least two sections were imaged from three WT and KIN animals with similar findings.

    Article Snippet: Primary antibodies utilized in this study were: ATXN2 (BD Biosciences #611378, 1:100; Proteintech #21776-1-AP, 1:200), CALB1 (Cell Signaling #13176, 1:1000), CC1 (Millipore #OP80, 1:50), CNP (Cell Signaling #5664S, 1:100), MAG (Cell Signaling #9043S, 1:100), OLIG2 (Millipore #MABN50, 1:300), PABP (Abcam #ab21060, 1:200), PDGFRα (Novus, #AF1062, 1:100), QKI6 (Neuromab #75-190, 1:200).

    Techniques: Mutagenesis, Immunohistochemical staining

    a, Protein levels of QKI5, QKI6 and QKI7 were measured in KIN cerebellum (Cb) at pre-onset (3 mo) and terminal (14 mo) disease stages with age-matched WT controls. QKI5 remained upregulated and QKI7 remained downregulated in KIN tissue throughout the disease course, but QKI6 showed a pre-onset upregulation that transformed into a strong downregulation at the terminal stage, mimicking a profile usually displayed by proteins sequestrated into aggregation in the disease course. ACTB was used as loading control in quantitative immunoblots. Each data point represents a single animal. b, Immunohistochemical assessment of QKI6 (green) localization in WT and KIN cerebellar WM at the terminal stage (14 mo) showed its diffuse cytosolic distribution in WT samples, and its sequestration into cytosolic aggregates in KIN samples marked by SG marker PABP (red). DAPI (blue) marks the nuclei. Transcript levels of Qki5 , Qki6 and Qki7 were measured with specific primers designed for qRT-PCR in KIN (c) , KO (d) and transgenic (Tg) ATXN2 -Q58 mouse (e) tissues at different disease stages with age-matched WT controls. Only late-onset dysregulations were observed in KIN cerebellum (Cb) and spinal cord (SC), without a change in KO or Tg ATXN2 -Q58 cerebellum. Actb was used as housekeeping gene in qRT-PCR experiments. Each data point represents a single animal.

    Journal: bioRxiv

    Article Title: ATXN2 polyglutamine expansion impairs QKI-dependent alternative splicing and oligodendrocyte maintenance

    doi: 10.1101/2025.08.08.669189

    Figure Lengend Snippet: a, Protein levels of QKI5, QKI6 and QKI7 were measured in KIN cerebellum (Cb) at pre-onset (3 mo) and terminal (14 mo) disease stages with age-matched WT controls. QKI5 remained upregulated and QKI7 remained downregulated in KIN tissue throughout the disease course, but QKI6 showed a pre-onset upregulation that transformed into a strong downregulation at the terminal stage, mimicking a profile usually displayed by proteins sequestrated into aggregation in the disease course. ACTB was used as loading control in quantitative immunoblots. Each data point represents a single animal. b, Immunohistochemical assessment of QKI6 (green) localization in WT and KIN cerebellar WM at the terminal stage (14 mo) showed its diffuse cytosolic distribution in WT samples, and its sequestration into cytosolic aggregates in KIN samples marked by SG marker PABP (red). DAPI (blue) marks the nuclei. Transcript levels of Qki5 , Qki6 and Qki7 were measured with specific primers designed for qRT-PCR in KIN (c) , KO (d) and transgenic (Tg) ATXN2 -Q58 mouse (e) tissues at different disease stages with age-matched WT controls. Only late-onset dysregulations were observed in KIN cerebellum (Cb) and spinal cord (SC), without a change in KO or Tg ATXN2 -Q58 cerebellum. Actb was used as housekeeping gene in qRT-PCR experiments. Each data point represents a single animal.

    Article Snippet: Primary antibodies utilized in this study were: ATXN2 (BD Biosciences #611378, 1:100; Proteintech #21776-1-AP, 1:200), CALB1 (Cell Signaling #13176, 1:1000), CC1 (Millipore #OP80, 1:50), CNP (Cell Signaling #5664S, 1:100), MAG (Cell Signaling #9043S, 1:100), OLIG2 (Millipore #MABN50, 1:300), PABP (Abcam #ab21060, 1:200), PDGFRα (Novus, #AF1062, 1:100), QKI6 (Neuromab #75-190, 1:200).

    Techniques: Transformation Assay, Control, Western Blot, Immunohistochemical staining, Marker, Quantitative RT-PCR, Transgenic Assay